98 related articles for article (PubMed ID: 22414964)
1. Equivalent effects on fecal reactive oxygen species generation with oral supplementation of three iron compounds: ferrous sulfate, sodium iron EDTA and iron polymaltose.
Orozco MN; Arriaga C; Solomons NW; Schümann K
Ann Nutr Metab; 2012; 60(2):108-14. PubMed ID: 22414964
[TBL] [Abstract][Full Text] [Related]
2. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
Erichsen K; Ulvik RJ; Grimstad T; Berstad A; Berge RK; Hausken T
Aliment Pharmacol Ther; 2005 Nov; 22(9):831-8. PubMed ID: 16225492
[TBL] [Abstract][Full Text] [Related]
3. Oral administration of ferrous sulfate, but not of iron polymaltose or sodium iron ethylenediaminetetraacetic acid (NaFeEDTA), results in a substantial increase of non-transferrin-bound iron in healthy iron-adequate men.
Schümann K; Solomons NW; Romero-Abal ME; Orozco M; Weiss G; Marx J
Food Nutr Bull; 2012 Jun; 33(2):128-36. PubMed ID: 22908694
[TBL] [Abstract][Full Text] [Related]
4. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers.
Lund EK; Wharf SG; Fairweather-Tait SJ; Johnson IT
Am J Clin Nutr; 1999 Feb; 69(2):250-5. PubMed ID: 9989688
[TBL] [Abstract][Full Text] [Related]
5. Differences in circulating non-transferrin-bound iron after oral administration of ferrous sulfate, sodium iron EDTA, or iron polymaltose in women with marginal iron stores.
Schümann K; Solomons NW; Orozco M; Romero-Abal ME; Weiss G
Food Nutr Bull; 2013 Jun; 34(2):185-93. PubMed ID: 23964391
[TBL] [Abstract][Full Text] [Related]
6. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males.
Schümann K; Kroll S; Romero-Abal ME; Georgiou NA; Marx JJ; Weiss G; Solomons NW
Ann Nutr Metab; 2012; 60(2):98-107. PubMed ID: 22398912
[TBL] [Abstract][Full Text] [Related]
7. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
Toblli JE; Cao G; Angerosa M
Drug Des Devel Ther; 2015; 9():2585-97. PubMed ID: 26005335
[TBL] [Abstract][Full Text] [Related]
8. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children.
Dostal A; Baumgartner J; Riesen N; Chassard C; Smuts CM; Zimmermann MB; Lacroix C
Br J Nutr; 2014 Aug; 112(4):547-56. PubMed ID: 24916165
[TBL] [Abstract][Full Text] [Related]
9. Ferrous sulfate (Fe2+) had a faster effect than did ferric polymaltose (Fe3+) on increased oxidant status in children with iron-deficiency anemia.
Aycicek A; Koc A; Oymak Y; Selek S; Kaya C; Guzel B
J Pediatr Hematol Oncol; 2014 Jan; 36(1):57-61. PubMed ID: 23743961
[TBL] [Abstract][Full Text] [Related]
10. Iron supplementation in pregnancy--does the preparation matter?
Melamed N; Ben-Haroush A; Kaplan B; Yogev Y
Arch Gynecol Obstet; 2007 Dec; 276(6):601-4. PubMed ID: 17541618
[TBL] [Abstract][Full Text] [Related]
11. Moderate NaFeEDTA and ferrous sulfate supplementation can improve both hematologic status and oxidative stress in anemic pregnant women.
Han XX; Sun YY; Ma AG; Yang F; Zhang FZ; Jiang DC; Li Y
Asia Pac J Clin Nutr; 2011; 20(4):514-20. PubMed ID: 22094835
[TBL] [Abstract][Full Text] [Related]
12. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of iron from oral ferric polymaltose in humans.
Nielsen P; Gabbe EE; Fischer R; Heinrich HC
Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973
[TBL] [Abstract][Full Text] [Related]
14. Long-term consequences of iron-fortified flour consumption in nonanemic men.
Pouraram H; Elmadfa I; Dorosty AR; Abtahi M; Neyestani TR; Sadeghian S
Ann Nutr Metab; 2012; 60(2):115-21. PubMed ID: 22433920
[TBL] [Abstract][Full Text] [Related]
15. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme.
Sesink AL; Termont DS; Kleibeuker JH; Van der Meer R
Cancer Res; 1999 Nov; 59(22):5704-9. PubMed ID: 10582688
[TBL] [Abstract][Full Text] [Related]
16. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease.
Erichsen K; Hausken T; Ulvik RJ; Svardal A; Berstad A; Berge RK
Scand J Gastroenterol; 2003 May; 38(5):543-8. PubMed ID: 12795468
[TBL] [Abstract][Full Text] [Related]
17. Non-heme iron as ferrous sulfate does not interact with heme iron absorption in humans.
Gaitán D; Olivares M; Lönnerdal B; Brito A; Pizarro F
Biol Trace Elem Res; 2012 Dec; 150(1-3):68-73. PubMed ID: 22935997
[TBL] [Abstract][Full Text] [Related]
18. Effect of NaFeEDTA-fortified soy sauce on zinc absorption in children.
Li M; Wu J; Ren T; Wang R; Li W; Piao J; Wang J; Yang X
Food Funct; 2015 Mar; 6(3):788-92. PubMed ID: 25582850
[TBL] [Abstract][Full Text] [Related]
19. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta BC
J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
[No Abstract] [Full Text] [Related]
20. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy.
Khalafallah A; Dennis A; Bates J; Bates G; Robertson IK; Smith L; Ball MJ; Seaton D; Brain T; Rasko JE
J Intern Med; 2010 Sep; 268(3):286-95. PubMed ID: 20546462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
